MMC241220P290000
- 0.00
- 0.000.00%
Marsh & McLennan Newsroom
Jefferies Maintains Marsh & McLennan(MMC.US) With Hold Rating, Raises Target Price to $238
Jefferies Adjusts Marsh & McLennan Price Target to $238 From $233, Maintains Hold Rating
Here's How Much $100 Invested In Marsh & McLennan 10 Years Ago Would Be Worth Today
Jim Cramer on Marsh & McLennan Companies, Inc. (MMC): 'They Just Keep Raising Rates'
Most and Least Shorted S&P 500 Financial Stocks in November
RBC Capital Upgrades Marsh & McLennan to Outperform, Raises Price Target to $250
RBC Capital Upgrades Marsh & McLennan(MMC.US) to Buy Rating, Raises Target Price to $250
(MMC) - Analyzing Marsh & McLennan's Short Interest
Despite Economic Uncertainty, US Employers Maintain Elevated Compensation Budgets for 2025, According to Mercer
Marsh & McLennan Currently Down Seven Consecutive Days, On Pace for Longest Losing Streak Since December 2018 -- Data Talk
How Is Marsh & Mclennan's Stock Performance Compared to Other Insurance Stocks?
Here's Why Investors Should Hold Marsh & McLennan Stock for Now
U.S. Stock Market Prospects | Cryptocurrency concept stocks explode this year! Coinbase's stock price approaches a three-year high; electric vehicles press the accelerator! Ideal Auto skyrockets nearly 7% overnight.
The pharmaceutical has been included in the medical insurance bureau! The Chinese biotech pharmaceutical giant beigene's stock price has returned to the $200 mark, surging more than 7% last night.
'Bunker' and 'Booster' Stocks in the U.S. – Which Would Perform Better in a Downturn Vs. Upturn?
US stocks mining | Nuclear energy stocks collectively rise! CEG's annual increase is nearly 130%; aerospace stocks celebrate together! SpaceX's formidable rival Rocket Lab has surged over 360% this year.
Hundred-billion collaboration agreement finalized! Biotechnology company sarepta therapeutics surged nearly 14% overnight, approaching a three-month high; Medical reimbursement limit increased! Medical diagnostic company exact sciences rose 9% last night.
What Are Wall Street Analysts' Target Price for Marsh & McLennan Stock?
Credit Benchmark and Oliver Wyman Launch IRB Nexus to Help Banks Improve Model Performance and Calibration
Marsh & McLennan Companies Hits 5-week High
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Evercore ISI Group Reinstates Outperform on Marsh & McLennan, Announces $242 Price Target